Vega BioImaging
1 known investors
Vega BioImaging develops multiplex cancer diagnostic kits that use patented functionalized nanobead technology combined with optical microscopy and AI algorithms to detect biomarkers quantitatively. Its platform serves pathologists for cancer subtyping and treatment response prediction, positioned as an alternative to traditional immunohistochemistry in precision medicine.
Investors · 1
Frequently asked questions
- What does Vega BioImaging do?
- Vega BioImaging develops multiplex cancer diagnostic kits that use patented functionalized nanobead technology combined with optical microscopy and AI algorithms to detect biomarkers quantitatively. Its platform serves pathologists for cancer subtyping and treatment response prediction, positioned as an alternative to traditional immunohistochemistry in precision medicine.
- Who are Vega BioImaging's investors?
- Vega BioImaging's investors include Front Row Ventures.